Annual FCF
-$100.60 M
+$52.95 M+34.48%
December 31, 2023
Summary
- As of February 7, 2025, KRYS annual free cash flow is -$100.60 million, with the most recent change of +$52.95 million (+34.48%) on December 31, 2023.
- During the last 3 years, KRYS annual FCF has fallen by -$59.68 million (-145.82%).
- KRYS annual FCF is now -7486.95% below its all-time high of -$1.33 million, reached on December 31, 2016.
Performance
KRYS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$57.81 M
+$63.11 M+1190.98%
September 30, 2024
Summary
- As of February 7, 2025, KRYS quarterly free cash flow is $57.81 million, with the most recent change of +$63.11 million (+1190.98%) on September 30, 2024.
- Over the past year, KRYS quarterly FCF has increased by +$80.82 million (+351.28%).
- KRYS quarterly FCF is now at all-time high.
Performance
KRYS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$58.06 M
+$80.82 M+355.13%
September 30, 2024
Summary
- As of February 7, 2025, KRYS TTM free cash flow is $58.06 million, with the most recent change of +$80.82 million (+355.13%) on September 30, 2024.
- Over the past year, KRYS TTM FCF has increased by +$177.13 million (+148.76%).
- KRYS TTM FCF is now at all-time high.
Performance
KRYS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
KRYS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.5% | +351.3% | +148.8% |
| 3 y3 years | -145.8% | +309.9% | +137.8% |
| 5 y5 years | -761.4% | +309.9% | +137.8% |
KRYS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +34.5% | at high | +193.6% | at high | +130.9% |
| 5 y | 5-year | -301.0% | +34.5% | at high | +193.6% | at high | +130.9% |
| alltime | all time | -7486.9% | +34.5% | at high | +193.6% | at high | +130.9% |
Krystal Biotech Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $57.81 M(-1191.0%) | $58.06 M(-355.1%) |
| Jun 2024 | - | -$5.30 M(-136.2%) | -$22.76 M(-58.2%) |
| Mar 2024 | - | $14.63 M(-261.1%) | -$54.44 M(-45.9%) |
| Dec 2023 | -$100.60 M(-34.5%) | -$9.08 M(-60.5%) | -$100.60 M(-15.5%) |
| Sep 2023 | - | -$23.01 M(-37.8%) | -$119.07 M(-8.3%) |
| Jun 2023 | - | -$36.98 M(+17.3%) | -$129.81 M(-14.8%) |
| Mar 2023 | - | -$31.54 M(+14.5%) | -$152.40 M(-0.7%) |
| Dec 2022 | -$153.55 M(+32.1%) | -$27.55 M(-18.4%) | -$153.55 M(-18.2%) |
| Sep 2022 | - | -$33.74 M(-43.4%) | -$187.78 M(+3.0%) |
| Jun 2022 | - | -$59.57 M(+82.3%) | -$182.29 M(+33.2%) |
| Mar 2022 | - | -$32.68 M(-47.1%) | -$136.83 M(+17.7%) |
| Dec 2021 | -$116.27 M(+184.1%) | -$61.78 M(+118.7%) | -$116.27 M(+66.8%) |
| Sep 2021 | - | -$28.25 M(+100.1%) | -$69.72 M(+33.0%) |
| Jun 2021 | - | -$14.12 M(+16.4%) | -$52.44 M(+15.7%) |
| Mar 2021 | - | -$12.13 M(-20.4%) | -$45.32 M(+10.7%) |
| Dec 2020 | -$40.93 M | -$15.23 M(+39.0%) | -$40.93 M(+17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$10.96 M(+56.6%) | -$34.97 M(+18.7%) |
| Jun 2020 | - | -$7.00 M(-9.5%) | -$29.45 M(+5.6%) |
| Mar 2020 | - | -$7.74 M(-16.6%) | -$27.90 M(+11.2%) |
| Dec 2019 | -$25.09 M(+114.8%) | -$9.28 M(+70.5%) | -$25.09 M(+21.6%) |
| Sep 2019 | - | -$5.44 M(-0.1%) | -$20.63 M(+14.9%) |
| Jun 2019 | - | -$5.45 M(+10.7%) | -$17.96 M(+26.2%) |
| Mar 2019 | - | -$4.92 M(+2.1%) | -$14.23 M(+21.9%) |
| Dec 2018 | -$11.68 M(+184.9%) | -$4.82 M(+74.0%) | -$11.68 M(+27.7%) |
| Sep 2018 | - | -$2.77 M(+61.5%) | -$9.14 M(+22.2%) |
| Jun 2018 | - | -$1.72 M(-27.6%) | -$7.48 M(+20.6%) |
| Mar 2018 | - | -$2.37 M(+3.6%) | -$6.21 M(+51.3%) |
| Dec 2017 | -$4.10 M(+209.2%) | -$2.29 M(+105.9%) | -$4.10 M(+126.0%) |
| Sep 2017 | - | -$1.11 M(+152.3%) | -$1.81 M(+157.7%) |
| Jun 2017 | - | -$440.00 K(+66.7%) | -$704.00 K(+166.7%) |
| Mar 2017 | - | -$264.00 K | -$264.00 K |
| Dec 2016 | -$1.33 M | - | - |
FAQ
- What is Krystal Biotech annual free cash flow?
- What is the all time high annual FCF for Krystal Biotech?
- What is Krystal Biotech annual FCF year-on-year change?
- What is Krystal Biotech quarterly free cash flow?
- What is the all time high quarterly FCF for Krystal Biotech?
- What is Krystal Biotech quarterly FCF year-on-year change?
- What is Krystal Biotech TTM free cash flow?
- What is the all time high TTM FCF for Krystal Biotech?
- What is Krystal Biotech TTM FCF year-on-year change?
What is Krystal Biotech annual free cash flow?
The current annual FCF of KRYS is -$100.60 M
What is the all time high annual FCF for Krystal Biotech?
Krystal Biotech all-time high annual free cash flow is -$1.33 M
What is Krystal Biotech annual FCF year-on-year change?
Over the past year, KRYS annual free cash flow has changed by +$52.95 M (+34.48%)
What is Krystal Biotech quarterly free cash flow?
The current quarterly FCF of KRYS is $57.81 M
What is the all time high quarterly FCF for Krystal Biotech?
Krystal Biotech all-time high quarterly free cash flow is $57.81 M
What is Krystal Biotech quarterly FCF year-on-year change?
Over the past year, KRYS quarterly free cash flow has changed by +$80.82 M (+351.28%)
What is Krystal Biotech TTM free cash flow?
The current TTM FCF of KRYS is $58.06 M
What is the all time high TTM FCF for Krystal Biotech?
Krystal Biotech all-time high TTM free cash flow is $58.06 M
What is Krystal Biotech TTM FCF year-on-year change?
Over the past year, KRYS TTM free cash flow has changed by +$177.13 M (+148.76%)